Abstract
A variety of leptin actions require a re-examination of classic concepts of metabolic diseases. Here we present evidence for two physiologic pathways: a pathway that protects nonadipose tissues from overaccumulation of potentially toxic lipids and unrecognized paracrine interactions between α and β cells revealed by leptin's ability to suppress diabetic hyperglucagonemia. These observations strongly point to new therapeutic possibilities for both type 1 and type 2 diabetes.
Original language | English (US) |
---|---|
Pages (from-to) | 15-20 |
Number of pages | 6 |
Journal | Cell Metabolism |
Volume | 21 |
Issue number | 1 |
DOIs | |
State | Published - Jan 6 2015 |
ASJC Scopus subject areas
- Physiology
- Molecular Biology
- Cell Biology